Aerocrine Closes $50 Mln Debt, Equity Financing
Aerocrine has received $35 million in debt financing from OrbiMed and Novo. Aerocrine also raises SEK 95 million (approx. USD 15 million) of equity from OrbiMed and a number of institutional investors through a directed share issue. Aerocrine, of Solna, Sweden, is a medical products company.
30 April 2013•4 mins read
